HomeAI · summaries
Storia in 14 fonti
FDA panel confronting peptide controversy
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
